Eric Thomas Schmidt, Chief Financial Officer at Allogene Therapeutics, Inc. (ALLO), sold 26,800 shares at $35.96 ($944K) on 2020-09-21, disclosed to the SEC on 2020-09-22.
Open-market sale of $944k ALLO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.76 | 9,889 | $344K | 36.4% |
| 2 | $34.76 | 9,889 | $344K | 36.4% |
| 3 | $35.96 | 3,200 | $115K | 12.2% |
| 4 | $37.04 | 1,911 | $71K | 7.5% |
| 5 | $37.04 | 1,911 | $71K | 7.5% |
| Total | $35.23 avg | 26,800 |
| $944K |
| 100% |
| Filing → |
| ALLO | SELL | 2021-01-19 | $1.9M | — | Filing → |
| ALLO | SELL | 2020-11-18 | $644K | — | Filing → |
| ALLO | SELL | 2020-10-16 | $1.2M | — | Filing → |